INFUSYSTEM HOLDINGS, INC (INFU) Operating Margin
- Operating margin · 12 months: Value 9.26%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 9.26% | Operating income / revenue. Period ending 2026-06-30. $13.27M ÷ $143.34M × 100 ≈ 9.26% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 13.27M USD | Operating Income (Loss) |
| Revenue | 143.34M USD | |
| Cost of products and services | 60.98M USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.27M | $143.34M | $60.98M | (m) | (m) | 9.26% |
| 2026-03-31 | $12.89M | $142.40M | $61.59M | (m) | (m) | 9.05% |
| 2025-12-31 | $11.92M | $143.44M | $63.14M | (m) | (m) | 8.31% |
| 2025-09-30 | $10.82M | $141.05M | $62.98M | (m) | (m) | 7.67% |
| 2025-06-30 | $10.28M | $139.89M | $63.58M | (m) | (m) | 7.35% |
| 2025-03-31 | $8.35M | $137.58M | $64.49M | (m) | (m) | 6.07% |
| 2024-12-31 | $6.89M | $134.86M | $64.46M | (m) | (m) | 5.11% |
| 2024-09-30 | $5.53M | $132.78M | $63.89M | (m) | (m) | 4.16% |
| 2024-06-30 | $3.96M | $129.37M | $63.90M | (m) | (m) | 3.06% |
| 2024-03-31 | $3.35M | $127.41M | $62.78M | (m) | (m) | 2.63% |
| 2023-12-31 | $4.09M | $125.78M | $62.68M | (m) | (m) | 3.25% |
| 2023-09-30 | $3.87M | $122.84M | $58.53M | (m) | (m) | 3.15% |
| 2023-06-30 | $3.11M | $118.21M | $53.93M | (m) | (m) | 2.63% |
| 2023-03-31 | $2.07M | $113.52M | $50.78M | (m) | (m) | 1.83% |
| 2022-12-31 | $1.65M | $109.91M | $47.34M | (m) | (m) | 1.50% |
| 2022-09-30 | $2.23M | $107.60M | $45.80M | (m) | (m) | 2.07% |
| 2022-06-30 | $933.00K | $106.89M | $46.05M | (m) | (m) | 0.87% |
| 2022-03-31 | $1.42M | $104.68M | $43.69M | (m) | (m) | 1.36% |
| 2021-12-31 | $2.82M | $102.38M | $42.19M | (m) | (m) | 2.75% |
| 2021-09-30 | $2.25M | $100.57M | $40.69M | (m) | (m) | 2.24% |
| 2021-06-30 | $5.86M | $99.13M | $39.39M | (m) | (m) | 5.91% |
| 2021-03-31 | $9.67M | $100.30M | $39.63M | (m) | (m) | 9.64% |
| 2020-12-31 | $8.83M | $97.39M | $38.63M | (m) | (m) | 9.06% |
| 2020-09-30 | $9.10M | $94.39M | $37.68M | (m) | (m) | 9.64% |
| 2020-06-30 | $7.51M | $90.75M | $36.92M | (m) | (m) | 8.28% |
| 2020-03-31 | $3.98M | $84.47M | $35.27M | (m) | (m) | 4.71% |
| 2019-12-31 | $3.52M | $81.11M | $34.23M | (m) | (m) | 4.35% |
| 2019-09-30 | $2.34M | $76.97M | $24.82M | (m) | (m) | 3.04% |
| 2019-06-30 | $582.00K | $72.16M | $22.58M | (m) | (m) | 0.81% |
| 2019-03-31 | $-593.00K | $68.85M | $20.94M | (m) | (m) | -0.86% |
| 2018-12-31 | $415.00K | $67.14M | $19.33M | (m) | (m) | 0.62% |
| 2018-09-30 | $-1.02M | $68.47M | $18.93M | (m) | (m) | -1.49% |
| 2018-06-30 | $-367.00K | $69.38M | $18.49M | (m) | (m) | -0.53% |
| 2018-03-31 | $-1.25M | $69.91M | $18.31M | (m) | (m) | -1.80% |
| 2017-12-31 | $-3.81M | $71.08M | $18.37M | (m) | (m) | -5.36% |
| 2017-09-30 | $-2.96M | $69.04M | $17.50M | (m) | (m) | -4.28% |
| 2017-06-30 | $-2.94M | $68.68M | $17.07M | (m) | (m) | -4.28% |
| 2017-03-31 | $-1.41M | $69.86M | $17.24M | (m) | (m) | -2.02% |
| 2016-12-31 | $974.00K | $70.50M | $16.21M | (m) | (m) | 1.38% |
| 2016-09-30 | $3.92M | $72.39M | $15.86M | (m) | (m) | 5.41% |
| 2016-06-30 | $8.54M | $76.34M | $15.43M | (m) | (m) | 11.19% |
| 2016-03-31 | $8.48M | $74.44M | $14.29M | (m) | (m) | 11.39% |
| 2015-12-31 | $8.86M | $72.13M | $13.80M | (m) | (m) | 12.29% |
| 2015-09-30 | $8.35M | $68.85M | $13.39M | (m) | (m) | 12.13% |
| 2015-06-30 | $8.09M | $66.77M | $13.03M | (m) | (m) | 12.11% |
| 2015-03-31 | $9.11M | $65.97M | $12.29M | (m) | (m) | 13.80% |
| 2014-12-31 | $9.33M | $66.49M | $12.16M | (m) | (m) | 14.03% |
| 2014-09-30 | $9.02M | $67.40M | $12.12M | (m) | (m) | 13.38% |
| 2014-06-30 | $8.50M | $66.53M | $11.65M | (m) | (m) | 12.77% |
| 2014-03-31 | $7.02M | $64.82M | $11.59M | (m) | (m) | 10.83% |
| 2013-12-31 | $5.90M | $62.28M | $11.27M | (m) | (m) | 9.47% |
| 2013-09-30 | $5.00M | $61.34M | $10.58M | (m) | (m) | 8.15% |
| 2013-06-30 | $4.00M | $59.77M | $10.21M | (m) | (m) | 6.69% |
| 2013-03-31 | $3.17M | $59.18M | $9.51M | (m) | (m) | 5.35% |
| 2012-12-31 | $2.00M | $58.83M | $9.16M | (m) | (m) | 3.40% |
| 2012-09-30 | $-260.00K | $56.64M | $9.23M | (m) | (m) | -0.46% |
| 2012-06-30 | $-23.68M | $56.97M | $9.20M | (m) | (m) | -41.56% |
| 2012-03-31 | $-67.10M | $56.03M | $9.22M | (m) | (m) | -119.75% |
| 2011-12-31 | $-66.36M | $54.64M | $9.13M | (m) | (m) | -121.45% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-938.00K | $47.23M | $7.73M | (m) | (m) | -1.99% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $5.33M | $38.96M | $6.20M | (m) | (m) | 13.67% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |